Europe Research Roundup: AstraZeneca, Ericsson, Gsk
15/09/2022 08:32
Sept 15 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including
AstraZeneca, Ericsson and Gsk, on Thursday.
HIGHLIGHTS
* AstraZeneca AZN.L : Credit Suisse cuts to neutral from outperform
* BT Group Plc BT.L : HSBC raises to buy from hold
* Ericsson ERICb.ST : Credit Suisse cuts to underperform from outperform
* Gsk GSK.L : Credit Suisse raises to neutral
* Novartis AG NOVN.S : Credit Suisse cuts to underperform
Following is a summary of research actions on European companies reported by Reuters on Thursday. Stock entries are in
alphabetical order.
* Almirall SA ALM.MC : Credit Suisse cuts target price to EUR 10 from EUR 12
* AstraZeneca AZN.L : Credit Suisse cuts to neutral from outperform
* Benevolentai SA BAI.AS : JP Morgan initiates coverage with neutral rating
* Benevolentai SA BAI.AS : JP Morgan initiates coverage with EUR 5.10 target price
* BT Group Plc BT.L : HSBC raises to buy from hold
* Dechra Pharmaceuticals Plc DPH.L : RBC cuts target price to 4,000p from 4,200p
* Deutsche Telekom DTEGN.DE : HSBC raises target price to EUR 26.5 from EUR 24
* D'Ieteren Group NV IETB.BR : Jefferies initiates with buy rating and EUR 210 target price
* Ericsson ERICb.ST : Credit Suisse cuts target price to SEK 69 from SEK 113
* Ericsson ERICb.ST : Credit Suisse cuts to underperform from outperform
* Fever-Tree FEVR.L : HSBC cuts target price to 780p from 800p
* Genmab A/S GMAB.CO : Credit Suisse raises target price to DKK 2800 from DKK 2600
* Gsk GSK.L : Credit Suisse cuts target price to 1430p from 1630p
* Gsk GSK.L : Credit Suisse raises to neutral
* H Lundbeck A/S HLUNb.CO : Credit Suisse cuts target price to DKK 31 from DKK 32.6
* H Lundbeck A/S HLUNb.CO : Credit Suisse raises to neutral from underperform
* Hikma HIK.L : Jefferies cuts target price to 2020p from 2290p
* Johnson Service Plc JSG.L : HSBC cuts target price to 97p from 156p
* Johnson Service Plc JSG.L : HSBC cuts to hold from buy
* KBC KBC.BR : HSBC raises target price to EUR 73 from EUR 69.42
* Kion Group KGX.DE : HSBC cuts target price to EUR 43 from EUR 74
* Marimekko Oyj MEKKO.HE : Evli Research cuts target price to EUR 12 from EUR 13.2
* Marimekko Oyj MEKKO.HE : Evli Research raises to buy from hold
* Merck KGaA MRCG.DE : Jefferies raises target price to EUR 210 from EUR 205
* Nokia Oyj NOKIA.HE : Credit Suisse raises target price to EUR 6.31 from EUR 5.45
* Nokia Oyj NOKIA.HE : Credit Suisse raises to outperform from neutral
* Novartis AG NOVN.S : Credit Suisse cuts target price to CHF 78 from CHF 88
* Novartis AG NOVN.S : Credit Suisse cuts to underperform
* Proximus PROX.BR : HSBC cuts target price to EUR 12.5 from EUR 16
* Redrow Plc RDW.L : Jefferies cuts target price to 768p from 780p
* Roche Holding AG ROG.S : Credit Suisse raises to outperform
* Roche Holding AG ROG.S : Credit Suisse raises target price to CHF 375 from CHF 350
* Sanofi SASY.PA : Credit Suisse cuts target price to EUR 106 from EUR 110
* Swedish Orphan Biovitrum SOBIV.ST : Jefferies raises target price to SEK 295 from SEK 260
* Technoprobe SpA TPRO.MI : Berenberg initiates coverage with hold rating and EUR 7.90 PT
* Telecom Italia TLIT.MI : HSBC cuts target price to EUR 0.2 from EUR 0.4
* Telecom Italia TLIT.MI : HSBC cuts to hold from buy
* Telenor TEL.OL : HSBC cuts target price to NOK 125 from NOK 135
* UCB SA UCB.BR : Credit Suisse cuts target price to EUR 68 from EUR 86
* UCB SA UCB.BR : Credit Suisse cuts to underperform from neutral
* Vodafone Group VOD.L : HSBC cuts target price to 160p from 175p
(Compiled by Bengaluru Newsroom)
((Diaries@thomsonreuters.com))